Chinese firms Adagene, Cloopen eye US listings

By Jonathan Breen
20 Jan 2021

Cloopen Group Holding, a cloud-based communication provider, is planning to raise at least $100m from a US IPO of American depositary shares (ADS).

CICC, Citi and Goldman Sachs, the joint underwriters, filed paperwork with the US regulator for the New York Stock Exchange listing on Tuesday.

Clinical-stage biopharmaceutical company Adagene also submitted an IPO prospectus with the US Securities and Exchange Commission on Tuesday. Its Nasdaq ADS listing has a placeholder ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial